A novel RGD-toxin protein, Lj-RGD3, from the buccal gland secretion of Lampetra japonica impacts diverse biological activities

Biochimie

Volumn 92, Issue 10, 2010, Pages 1387-1396

  Wang, Jihong ^a   Han, Xiaoxi ^a   Yang, Hsinshen ^b   Lu, Li ^c   Wu, Yu ^a   Liu, Xin ^a   Guo, Renyong ^a   Zhang, Yan ^a   Zhang, Yaqian ^a   Li, Qingwei ^a  

^a LIAONING NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

^c DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Integrin; Lampetra japonica; Platelet aggregation; RGD toxin protein

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; LJ RGD3 TOXIN PROTEIN; UNCLASSIFIED DRUG; VITRONECTIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEEK; CLONING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA LIBRARY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; FISH; HUMAN; HUMAN CELL; IC 50; LAMPETRA JAPONICA; LAMPREY; NONHUMAN; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

AMINO ACID MOTIFS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CELLS, CULTURED; CHEEK; CHICK EMBRYO; DNA, COMPLEMENTARY; FISH VENOMS; GENE LIBRARY; HUMANS; LAMPREYS; OLIGOPEPTIDES; PLATELET AGGREGATION INHIBITORS;

HIRUDINIDA; IXODIDA; LETHENTERON JAPONICUM;

EID: 77957115272     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.07.001     Document Type: Article

References (50)

1. Berman A.E., Kozlova N.I. Integrins: structure and functions. Membr. Cell. Biol. 2000, 13:207-244.
2. Humphries M.J. Integrin structure. Biochem. Soc. Trans. 2000, 28:311-339.
3. Lu X., Lu D., Scully M.F., Kakkar V.V. Integrins in drug targeting-RGD templates in toxins. Curr. Pharm. Des. 2006, 12:2749-2769.
4. Parise L.V., Lee J., Juliano R.L. New aspects of integrin signaling in cancer. Semin. Cancer Biol. 2000, 10:407-414.
5. Zhao J.H., Guan J.L. Role of focal adhesion kinase in signaling by the extracellular matrix. Prog. Mol. Subcell. Biol. 2000, 25:37-55.
6. Mercurio A.M., Bachelder R.E., Rabinovitz I., O'Connor K.L., Tani T., Shaw L.M. The metastatic odyssey: the integrin connection. Surg. Oncol. Clin. N Am. 2001, 10:313-328. viii-ix.
7. Stockbauer K.E., Magoun L., Liu M., Burns E.H., Gubba S., Renish S., Pan X., Bodary S.C., Baker E., Coburn J., Leong J.M., Musser J.M. A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:242-247.
8. Behera A.K., Durand E., Cugini C., Antonara S., Bourassa L., Hildebrand E., Hu L.T., Coburn J. Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes. Cell. Microbiol. 2008, 10:320-331.
9. Everest P., Li J., Douce G., Charles I., De Azavedo J., Chatfield S., Dougan G., Roberts M. Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells. Microbiology 1996, 142(Pt 11):3261-3268.
10. Stewart P.L., Chiu C.Y., Huang S., Muir T., Zhao Y., Chait B., Mathias P., Nemerow G.R. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization. EMBO J. 1997, 16:1189-1198.
11. Alcala P., Feliu J.X., Aris A., Villaverde A. Efficient accommodation of recombinant, foot-and-mouth disease virus RGD peptides to cell-surface integrins. Biochem. Biophys. Res. Commun. 2001, 285:201-206.
12. Borges A.A., Campos G.M., Moreli M.L., Souza R.L., Aquino V.H., Saggioro F.P., Figueiredo L.T. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect. 2006, 8:2324-2330.
13. Temming K., Schiffelers R.M., Molema G., Kok R.J. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist. Updat. 2005, 8:381-402.
14. Niewiarowski S., McLane M.A., Kloczewiak M., Stewart G.J. Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin. Hematol. 1994, 31:289-300.
15. Kini R.M., Chow G. Exogenous inhibitors of platelet aggregation from animal sources. Thromb. Haemost. 2001, 85:179-181.
16. Kini R.M. Platelet aggregation and exogenous factors from animal sources. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2004, 4:301-325.
17. Hong S.Y., Koh Y.S., Chung K.H., Kim D.S. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thromb. Res. 2002, 105:79-86.
18. Shebuski R.J., Ramjit D.R., Bencen G.H., Polokoff M.A. Characterization and platelet inhibitory activity of bitistatin, a potent arginine-glycine-aspartic acid-containing peptide from the venom of the viper Bitis arietans. J. Biol. Chem. 1989, 264:21550-21556.
19. Yeh C.H., Peng H.C., Yang R.S., Huang T.F. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells. Mol. Pharmacol. 2001, 59:1333-1342.
20. Yeh C.H., Peng H.C., Huang T.F. Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 1998, 92:3268-3276.
21. Kang I.C., Lee Y.D., Kim D.S. A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res. 1999, 59:3754-3760.
22. Kang I.C., Kim D.S., Jang Y., Chung K.H. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem. Biophys. Res. Commun. 2000, 275:169-173.
23. Trikha M., De Clerck Y.A., Markland F.S. Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res. 1994, 54:4993-4998.
24. Wang J.H., Wu Y., Ren F., Lu L., Zhao B.C. Cloning and characterization of Adinbitor, a novel disintegrin from the snake venom of Agkistrodon halys brevicaudus stejneger. Acta Biochim. Biophys. Sin. (Shanghai) 2004, 36:425-429.
25. Scarborough R.M., Rose J.W., Hsu M.A., Phillips D.R., Fried V.A., Campbell A.M., Nannizzi L., Charo I.F. Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J. Biol. Chem. 1991, 266:9359-9362.
26. Fernandez J.H., Silva C.A., Assakura M.T., Camargo A.C., Serrano S.M. Molecular cloning, functional expression, and molecular modeling of bothrostatin, a new highly active disintegrin from Bothrops jararaca venom. Biochem. Biophys. Res. Commun. 2005, 329:457-464.
27. Minea R., Swenson S., Costa F., Chen T.C., Markland F.S. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol. Haemost. Thromb. 2005, 34:177-183.
28. Galan J.A., Sanchez E.E., Rodriguez-Acosta A., Soto J.G., Bashir S., McLane M.A., Paquette-Straub C., Perez J.C. Inhibition of lung tumor colonization and cell migration with the disintegrin crotatroxin 2 isolated from the venom of Crotalus atrox. Toxicon 2008, 51:1186-1196.
29. Krezel A.M., Ulmer J.S., Wagner G., Lazarus R.A. Recombinant decorsin: dynamics of the RGD recognition site. Protein Sci. 2000, 9:1428-1438.
30. Mazur P., Henzel W.J., Seymour J.L., Lazarus R.A. Ornatins: potent glycoprotein IIb-IIIa antagonists and platelet aggregation inhibitors from the leech Placobdella ornata. Eur. J. Biochem. 1991, 202:1073-1082.
31. Wang X., Coons L.B., Taylor D.B., Stevens S.E., Gartner T.K. Variabilin, a novel RGD-containing antagonist of glycoprotein IIb-IIIa and platelet aggregation inhibitor from the hard tick Dermacentor variabilis. J. Biol. Chem. 1996, 271:17785-17790.
32. Mans B.J., Louw A.I., Neitz A.W. Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the Kunitz-BPTI fold. J. Biol. Chem. 2002, 277:21371-21378.
33. Wierzbicka-Patynowski I., Niewiarowski S., Marcinkiewicz C., Calvete J.J., Marcinkiewicz M.M., McLane M.A. Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins. J. Biol. Chem. 1999, 274:37809-37814.
34. Scibelli A., Roperto S., Manna L., Pavone L.M., Tafuri S., Della Morte R., Staiano N. Engagement of integrins as a cellular route of invasion by bacterial pathogens. Vet. J. 2007, 173:482-491.
35. de Lima D.C., Alvarez Abreu P., de Freitas C.C., Santos D.O., Borges R.O., Dos Santos T.C., Mendes Cabral L., Rodrigues C.R., Castro H.C. Snake venom: any clue for antibiotics and CAM?. Evid. Based Complement. Alternat. Med. 2005, 2:39-47.
36. Xiao R., Li Q.W., Perrett S., He R.Q. Characterisation of the fibrinogenolytic properties of the buccal gland secretion from Lampetra japonica. Biochimie 2007, 89:383-392.
37. Sun J., Wu Y., Wang J., Ma F., Liu X., Li Q. Novel translationally controlled tumor protein homologue in the buccal gland secretion of Lampetra japonica. Biochimie 2008, 90:1760-1768.
38. Gao Q., Pang Y., Wu Y., Ma F., Li Q.W. Expressed sequence tags (ESTs) analysis of the oral gland of Lampetra japonica. Yi Chuan Xue Bao 2005, 32:1045-1052.
39. Sambrook J., Maniatis T., Fritsch E.F. Molecular Cloning: A Laboratory Manual 1989, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. second ed.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
41. Schagger H., von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166:368-379.
42. McLane M.A., Gabbeta J., Rao A.K., Beviglia L., Lazarus R.A., Niewiarowski S. A comparison of the effect of decorsin and two disintegrins, albolabrin and eristostatin, on platelet function. Thromb. Haemost. 1995, 74:1316-1322.
43. Masood R., McGarvey M.E., Zheng T., Cai J., Arora N., Smith D.L., Sloane N., Gill P.S. Antineoplastic urinary protein inhibits Kaposi's sarcoma and angiogenesis in vitro and in vivo. Blood 1999, 93:1038-1044.
44. Leavesley D.I., Schwartz M.A., Rosenfeld M., Cheresh D.A. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell. Biol. 1993, 121:163-170.
45. McLane M.A., Vijay-Kumar S., Marcinkiewicz C., Calvete J.J., Niewiarowski S. Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins. FEBS Lett. 1996, 391:139-143.
46. Jia L.G., Shimokawa K., Bjarnason J.B., Fox J.W. Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon 1996, 34:1269-1276.
47. Kini R.M., Evans H.J. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 1992, 30:265-293.
48. Kang I.C., Chung K.H., Lee S.J., Yun Y., Moon H.M., Kim D.S. Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. Thromb. Res. 1998, 91:65-73.
49. Sinanan A.C., Machell J.R., Wynne-Hughes G.T., Hunt N.P., Lewis M.P. Alpha v beta 3 and alpha v beta 5 integrins and their role in muscle precursor cell adhesion. Biol. Cell 2008, 100:465-477.
50. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001, 305:285-298.